Kaye Mark 4
4 · Elevance Health, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Kaye Mark
EVP & CFO
Transactions
- Award
Common Stock
2024-03-01+2,755→ 23,031 total - Award
Employee Stock Option (Right to Buy)
2024-03-01+10,633→ 10,633 totalExercise: $499.11Exp: 2034-03-01→ Common Stock (10,633 underlying)
Footnotes (2)
- [F1]Represents restricted share units. Restrictions lapse as follows: 918 shares each on 3/1/2025 and 3/1/2026 and 919 shares on 3/1/2027.
- [F2]The option represents a right to purchase a total of 10,633 shares, and is exercisable in two installments of 3,544 shares each, and one installment of 3,545 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.